With the Codex risk share offer the grower only pays royalty on the area established by 31 October. Any failed areas declared by this date will not be liable for any royalty payment. BIPO are responsible for collecting royalty payments for this variety.
Codex has very vigorous autumn growth capability coupled with good spring vigour.
Codex carries the RLM7 phoma resistance gene offering maximum resilience against this pathogen and also demonstrates durable resistance to light leaf spot and good tolerance to verticillium stem stripe.
Such a combination offers strong establishment potential while excellent standing ability ensures seed yield is safeguarded through to harvest.
